The independent source for health policy research, polling, and news.
1,201-1,220 of 1,312 results
Charlie Oen was addicted to heroin as a teenager. At 25, he's now clean and a peer counselor in Lima, Ohio, where he tries to help people who started using drugs before he was born.
The federal government pays for kidney transplants. But the program only pays for essential anti-rejection drugs for three years. Many people can't afford them and can end up losing the kidney.
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.
Eight percent of those polled by the Kaiser Family Foundation say they have purchased medications outside of the U.S. to save money.
Advocates want alternatives to drugmaker's pricey pills for those who choose to die in Colorado and elsewhere.
A breakdown of winners — and a few losers — in the sprawling Cures Act approved by the House.
A Kaiser Health News analysis finds that the portion of federal marketplace plans requiring people to pay a third or more of the cost of specialty drugs have jumped from 37 to 63 percent since 2014.
Responding to a national epidemic, many state Medicaid programs are making the coverage rules for these opioid-based medicines tougher so that physicians will think twice before prescribing them. But some worry that legitimate pain patients could suffer.
Three lobbyists for every member of Congress in a push to pass a bill that increases research funding and speeds up approvals.
The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.
Colorado’s approval of a ballot measure sets the stage for efforts in other states.
Despite heavy opposition from the pharmaceutical industry and skepticism from policy experts, many voters see Proposition 61 as a way to protest the nation’s mounting drug prices.
The FDA’s drug-approval team is short more than 700 people and losing skilled staff members to the drug industry.
New research tracks how the widespread availability of these high-powered medications is causing a high rate of hospitalizations for opioid poisoning among children.
Majorities of Democrats, Republicans and independents support making sure high-cost drugs for chronic conditions are affordable.
Climbing drug prices are taking a toll on West Virginia's budget, some state legislators say. Expensive drugs fuel an increase in Medicaid spending, which leaves less money for schools and roads.
The plans sought to discourage costly HIV patients by not including their drug needs in formularies or requiring high cost sharing, a Harvard Law School group says in a complaint filed with HHS.
In a report out Tuesday, hospital groups said drug prices have skyrocketed since 2013, triggering a huge increase in what hospitals spend on pharmaceuticals.
KHN’s Julie Appleby joined forces with USA Today to create this chart, which details the various industry players and how they contribute to a prescription drug’s cost.
Two prescription medications have been found to be successful in helping many patients with alcohol cravings. Yet they are rarely used and many patients don’t know they exist.
© 2026 KFF